In vitro activity of the siderophore cephalosporin, cefiderocol, against molecularly characterized, carbapenem-non-susceptible Gram-negative bacteria from Europe

OBJECTIVES: Many carbapenem-resistant (CR) Gram-negative (GN) pathogens exhibit MDR, meaning few therapeutic options are available for CR-GN infections. Cefiderocol, a siderophore cephalosporin, has demonstrated in vitro efficacy against CR-GN bacteria. In the SIDERO-CR-2014–2016 surveillance study,...

Descripción completa

Detalles Bibliográficos
Autores principales: Longshaw, Christopher, Manissero, Davide, Tsuji, Masakatsu, Echols, Roger, Yamano, Yoshinori
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8210120/
https://www.ncbi.nlm.nih.gov/pubmed/34223017
http://dx.doi.org/10.1093/jacamr/dlaa060

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8210120/
https://www.ncbi.nlm.nih.gov/pubmed/34223017
http://dx.doi.org/10.1093/jacamr/dlaa060

Ejemplares similares